Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $95,771 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $4,151,414 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $4,151,414 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2009 | $538,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2010 | $119,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2008 | $353,143 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2011 | $363,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2012 | $390,683 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2013 | $333,000 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2014 | $764,142 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2015 | $34,827 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2009 | $1,169,891 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2010 | $1,517,457 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2005 | $680,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2008 | $1,187,088 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2011 | $1,490,125 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2012 | $1,416,700 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2013 | $375,037 | | enterprise zone |
Bristol-Myers Squibb Company, Inc. | Bristol-Myers Squibb | New York | state | 2002 | $275,000 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2004 | $17,000 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2005 | $57,000 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2008 | $5,666 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2003 | $257,000 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2009 | $453,858 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2010 | $753,841 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2011 | $698,828 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
ImClone Systems Corporation | Eli Lilly | New York | state | 2011 | $574,259 | | enterprise zone |
ImClone Systems LLC | Eli Lilly | New York | state | 2012 | $901,984 | | enterprise zone |
Pfizer, Inc. | Pfizer | New York | state | 2005 | $500,000 | | enterprise zone |
Pfizer, Inc. | Pfizer | New York | state | 2002 | $2,783,900 | | enterprise zone |
Pfizer, Inc. | Pfizer | New York | state | 2003 | $2,956,000 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2008 | $1,152,412 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2009 | $363,019 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2010 | $143,721 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2011 | $153,972 | | enterprise zone |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2012 | $146,985 | | enterprise zone |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2004 | $653,700 | | enterprise zone |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2003 | $4,885,774 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2004 | $1,130,588 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2005 | $1,985,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2003 | $939,077 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2008 | $2,196,897 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2009 | $2,600,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2010 | $1,980,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2001 | $620,000 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2002 | $828,938 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2011 | $2,366,358 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2012 | $1,457,431 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2013 | $2,311,702 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2014 | $1,028,677 | | enterprise zone |
Abbott Laboratories | Abbott Laboratories | Ohio | state | 2019 | undisclosed | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2016 | $5,514,595 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2016 | $67,627 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2017 | $1,583,114 | | enterprise zone |
Ethicon, Inc. | Johnson & Johnson | Texas | state | 2019 | undisclosed | | enterprise zone |
Abbott Laboratories | Abbott Laboratories | Texas | state | 2020 | undisclosed | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $2,334,260 | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2019 | $1,954,481 | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $1,927,300 | | enterprise zone |
Novozymes Blair, Inc. | Novo Holdings A/S | United States | federal | 2010 | $28,401,000 | | federal allocated tax credit |
Millipore Corporation | Merck KGaA (EMD) | United States | federal | 2009 | $608,447 | | federal grant |
EMD Serono Research Center, Inc. | Merck KGaA (EMD) | United States | federal | 2011 | $31,419 | | federal grant |
AstraZeneca Pharmaceuticals LP | AstraZeneca | United States | federal | 2012 | $2,713,491 | | federal grant |
GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $4,011,709 | | federal grant |
HI TECH Pharmacal Company | Akorn Inc. | United States | federal | 2012 | $603,688 | | federal grant |
GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $729,692 | | federal grant |
Morphotek, Inc. | Eisai | United States | federal | 2012 | $141,901 | | federal grant |
Astellas US LLC | Astellas Pharma | United States | federal | 2013 | $1,160,482 | | federal grant |
Sanofi Pasteur Vaxdesign Corp | Sanofi | United States | federal | 2010 | $1,499,990 | | federal grant |
Easel Biotechnologies, LLC | Bristol-Myers Squibb | United States | federal | 2014 | $1,201,621 | | federal grant |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2008 | $4,694,082 | | federal grant |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2008 | $9,994,970 | | federal grant |
Amyris, Inc. | Amyris | United States | federal | 2009 | $24,341,409 | | federal grant |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2013 | $2,500,000 | | federal grant |
Amyris, Inc. | Amyris | United States | federal | 2016 | $3,549,805 | | federal grant |
Novozymes North America, Inc. | Novo Holdings A/S | United States | federal | 2011 | $1,568,670 | | federal grant |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $360,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2008 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $270,000 | federal loan or loan guarantee |
Cholestech Corporation | Abbott Laboratories | United States | federal | 2007 | | $1,500,000 | federal loan or loan guarantee |
Gilead Sciences, Inc. | Gilead Sciences | United States | federal | 2011 | | $4,500,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2013 | | $3,375,000 | federal loan or loan guarantee |